Clinical Trials Browser

Phase 2 × Has results × PT-100 dipeptide × Clear all

NCT04171219 2025-05-16

Talabostat and Pembrolizumab for the Treatment of Advanced Solid Cancers

Phase 2 Terminated

31 enrolled 15 charts

Other solid neoplasm

Advanced Malignant Solid Neoplasm